Sidebar

Marija Ger  

Phone: +370 5 2234411
Email:

ORCID
ResearchGate

 

Research Group

 

Research Interests: Cell signaling
Cancer biology
Anticancer drug resistance
Cancer biomarkers
Proteomics 
Present Position: Researcher 
Education:
2009 - PhD in Natural (former Physical) sciences, biochemistry, Vilnius University
2003 - MSc in Biochemistry, Vilnius University
2001 - BSc in Biochemistry, Vilnius University
Experience (Past Positions): 2018–present - Researcher, Vilnius University
2007–2018 - Research assistant, Institute of Biochemistry (since 2010 – Vilnius University Institute of Biochemistry)
2001–2003 - Biologist, Institute of Biochemistry
1998–2000 - Laboratory assistant, Institute of Botany 
Molecular biology of the cell: proteomics (in Lithuanian or English) 
Publications: LABT_LMAVB 
GoogleScholar
Academic Cooperation: Vilnius University hospital Santaros klinikos, Lithuania

Projects and Grants:

2020–2023 “Screening for new methods for treatment of neurodegenerative disorders” (No. 01.2.2-LMT-K-718-03-0021), Agency for Science, Innovation and Technology; Investigator.
2020–2021 “Development of novel proteomics-based drug selection approach for pancreatic cancer individualized therapy” (DiaKasa2; S-SEN-20-16); Research Council of Lithuania; Investigator.
2018–2021 "Development of primary cell cultures technologies for the increased efficacy of chemotherapy" (J05-LVPA-K-03-0080); Agency for Science, Innovation and Technology; Investigator.
2016–2018 “New multifunctional nanobiosensor for early pancreatic cancer diagnostics” (DiaKASA SEN-01/2016); Research Council of Lithuania; Investigator.
2015–2018 “Investigation of synthesis regulation of proteins associated with Alzheimer disease development”, Research Council of Lithuania; Investigator.
2014–2016 “High throughput proteomics for cancer cell surface protein recognition by quantum Dots” (SUREDOT; MIP-033/2014); Research Council of Lithuania; Investigator.
2013 Biotechnology and biopharmacy: fundamental and applied research" (VP1-3.1-ŠMM-08-K-01-005); Research Council of Lithuania; Investigator.
2012–2013 “Creation of biologically active regular three-dimensional structures for tissue molecular bioengineering” (BIO-MATRIX); Agency for Science, Innovation and Technology; Investigator.
2011–2015 “Molecular mechanisms of chinones and polychinones in the redox reactions, cytotoxicity, signal transduction and proteomics” (VP1-3.1-ŠMM-07-K-01-103,); Research Council of Lithuania; Investigator.
2007 “The study of Ras protooncogen on intracellular trafficking by confocal microscopy” (T-52/07), State Studies Foundation; Investigator.
2005-2006 m. “Development of molecular markers for individualized cancer therapy” (B-05012), Research Council of Lithuania; Investigator.
2005 “Functional and proteomic analysis of tumor controlling protein kinase D” (T-05273), Research Council of Lithuania; Investigator.
2001–2003 “Complex diagnostics for Individualized therapy at the level of cancer cell gene expression”, Research Council of Lithuania; Investigator.
2010–2012 COST action “Urine and Kidney Proteomics” (EuroKUP, BM0702), action management committee member for Lithuania.

Qualification Improvement, Certificates: 2003 Institute of Bioorganic Chemistry, Russia. Course on yeast two hybrid system.
2008 Applied Biosystems, Germany. 4800 TOF/TOF and 4000 QTrap mass spectrometers training course. 
Research Dissemination: The author at the science communication website Techo.lt
"Doctor of Sciences: cancer is not our deadliest enemy"
Languages: Lithuanian (native), English, Russian, French, Japanese

 

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies. More information